Status:
COMPLETED
Costs, Health Status and Outcomes of CAP (Community-Acquired Pneumonia)
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Pneumonia
Eligibility:
All Genders
65+ years
Brief Summary
The purpose of this study is to collect additional data on hospitalized Community-Acquired Pneumonia (CAP) on health states, health outcomes and on (health) resources and estimate the differences in t...
Detailed Description
Within the study data on quality of life and various health and non-health resources and their costs is collected with the help of questionnaires administered at different points in time in different ...
Eligibility Criteria
Inclusion
- Only participants of the CAPITA trial. Therefore the inclusion criteria as applied in CAPITA are the baseline for the current study. Additionally all participants had to be consent and had to fill in a baseline EQ-5D questionnaire
- Additionally for CAP patients: Consent to be filling to participate as a CAP and the presence of CAP has to be confirmed by the independent adjudication committee of the main CAPITA trial
- Additionally for controls: Consent to be filling to participate as control
Exclusion
- The non-availability of a baseline EQ-5D score is an exclusion criterion for the prospectively followed cohorts (both CAP patients and controls)
- In all stages of the study, patients have the right to withdraw their consent and stop their participation in this study.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
48634 Patients enrolled
Trial Details
Trial ID
NCT00812084
Start Date
November 1 2008
End Date
October 1 2014
Last Update
June 12 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Questionnaires are filled in at participants home addresses
The Netherlands, Netherlands